Aenishänslin W, Bergoz R, Capitaine Y, Egger G, Etienne A, Fumagalli I, Güller R, Hammer B, Kobler E, Leuthold E
Schweiz Med Wochenschr. 1986 May 10;116(19):637-41.
In a Swiss multicenter double-blind trial ranitidine was given in doses of 300 mg nocte and 150 mg b.d. for the treatment of duodenal ulcer. Ninety-seven patients with endoscopically proven ulcer were treated for four, and in cases of non-healing for eight, weeks. Cumulative healing rates with 300 mg and 2 X 150 mg were 77% and 78% after four weeks and 90% and 94% after eight weeks respectively. 60 and 65% of the patients were asymptomatic after four weeks. Smoking did not adversely affect healing. Thus, ranitidine in a dose of 300 mg nocte is as effective as ranitidine in a dose of 150 mg b.d. in the treatment of duodenal ulcer.
在一项瑞士多中心双盲试验中,雷尼替丁以每晚300毫克和每日两次每次150毫克的剂量给药,用于治疗十二指肠溃疡。97例经内镜证实患有溃疡的患者接受了4周治疗,未愈合者接受了8周治疗。300毫克组和2×150毫克组在4周后的累积愈合率分别为77%和78%,8周后分别为90%和94%。4周后,60%和65%的患者无症状。吸烟对愈合无不利影响。因此,每晚300毫克剂量的雷尼替丁在治疗十二指肠溃疡方面与每日两次每次150毫克剂量的雷尼替丁效果相同。